Zach Collins
Partner at Mission Biocapital
About
A partner in San Francisco focusing on early-stage biopharmaceutical investments and company operations. His academic work at Harvard Medical School applied genome editing and single-cell sequencing to stem-cell differentiation studies, contributing to Science's 2018 Breakthrough of the Year.
Colleagues at Mission Biocapital
Cassidy Blundell
Partner at Mission Biocapital
Chaya Patel
Principal at Mission Biocapital
Chris Carlin
Chief Operations Officer and Chief Compliance Officer at Mission Biocapital
Clay Rowland
Investment Associate at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital
Josephine Brysting
Investment Analyst at Mission Biocapital